biomarker 2,051 words KG: ent-prot-c99e5a7f 2026-03-24
kind:biomarkersection:biomarkersstate:published
Contents

Neurogranin - Alzheimer's Disease Biomarker

🔬 Protein Info
Gene Symbolent-prot-c99e5a7f
Chromosome11p15
Synaptic markerExclusively expressed in neuronal dendrites
Released with synaptic lossDendritic degeneration releases Ng into CSF
AD-specificElevations more pronounced in AD than other dementias
Complementary to tauNg reflects synaptic pathology, tau reflects neuronal loss
De Vos et al., 2015First large-scale validation of neurogranin
Kvartsberg et al., 2019Showed neurogranin predicts progression from MCI to AD
Milà-Alomà et al., 2020Neurogranin adds value to AT(N) classification
Thorsdottir et al., 2017Neurogranin changes in prodromal AD[@thors2017]
Sens et al., 2018Elevated neurogranin in autosomal dominant AD[@sens2018]
Elevated neurograninConsistent with AD-type synaptic pathology
Normal neurograninLess likely AD or early stage
Combined with Aβ/tauImproves diagnostic accuracy
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Knowledge Graph

Related Hypotheses (25)

Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.71
ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro
Score: 0.68
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68
Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52

Related Analyses (19)

Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · completed

Related Experiments (30)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40
Brain Connectivity-Targeted tACS Trial in Early AD
clinical · proposed · Score: 0.95
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.90
s:** - Test whether HCN1 knockout specifically in EC layer I
falsification · proposed · Score: 0.40

See Also (15)

TREM2 Agonist Therapies for Alzheimer's Disease
therapeutic · Pages share 18 hypotheses
Tau Immunotherapy for Alzheimer's Disease
therapeutic · Pages share 18 hypotheses
Sodium Oligomannate (GV-971) for Alzheimer's Disease
therapeutic · Pages share 18 hypotheses
Siponimod for Alzheimer's Disease
therapeutic · Pages share 18 hypotheses
Nanomedicine Approaches to Alzheimer's Disease
therapeutic · Pages share 18 hypotheses